We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Why Can’t mTOR Inhibitors Kill Cancer?

News   Oct 06, 2017 | Original story from UT Health San Antonio

 
Why Can’t mTOR Inhibitors Kill Cancer?

Mitochondrial elongation, induced by mTOR-inhibiting drugs, contributes to cell survival. Credit: Facility for Electron Microscopy Research/McGill University Department of Anatomy and Cell Biology.

 
 
 

RELATED ARTICLES

Clinical Trial Results: Immune Therapy Reduces Risk of Aggressive Breast Cancer Recurrence

News

An immune therapy for the most aggressive form of breast cancer can substantially reduce the risk of the disease returning, according to a clinical trial led by Professor Peter Schmid of Queen Mary University of London.

READ MORE

Established Theory of Diet Impact on Lifespan Challenged

News

New research suggests that switching to a rich diet after eating a restricted diet can in fact decrease life expectancy and have negative effects on health.

READ MORE

Charting Cancer Genes With CRISPR

News

Researchers have used the gene cutting tool CRISPR to make cuts in DNA around lengthy tumor genes, which can be used to collect sequence information.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE